|
Lani,
Thanks for putting the numbers in to understandable terms for us math phobes. Seems like even the best treatment can be a two-edged sword. To put another spin on it, looks like my chance of distant recurrence anywhere in the body (w/o Herceptin) is estimated by Oncotype dx at 1 in 3 or 1 in 4; but my chance of getting brainmets specifically with Herceptin is 1 in 161. Seems like a reasonable risk, all things considered.
Hopeful
|